Experimental Irradiation (EI)
Experimental Irradiation (EI)
批准号:
10627267
负责人:
Meredith A Morgan
金额:
$9.44万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
未结题
起止时间:
1997-06-01 至 2028-05-31
关键词:
AnimalsAreaCancer CenterCancer Center Support GrantCancer ControlCell LineClinicalClinical ResearchCollaborationsConsultationsDevelopmental Therapeutics ProgramDoctor of PhilosophyDoseEnsureEquipmentFosteringFundingGlossaryHematopoiesisImmunologyIrradiation Shared ResourceKnowledgeMalignant NeoplasmsMedicalMichiganModelingMultimodal ImagingMusNamesNormal CellPhysicsPopulation SciencesRadiationRadiation therapyRadiobiologyRattusResearchResearch DesignResearch PersonnelResearch Project GrantsResourcesServicesSignal TransductionSystemTechnologyTimeTissuesTrainingTranslational ResearchTreatment ProtocolsUniversitiescancer cellcancer geneticsdosagedosimetryexperienceexperimental studyimage guidedinnovationinterestirradiationmemberprogramsradiation deliveryresearch studytooltumor microenvironment
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT (EXPERIMENTAL IRRADIATION SHARED RESOURCE)
The Experimental Irradiation Shared Resource (EI-SR) provides access to state-of-the-art equipment and expert
consultation for Rogel Cancer Center (Rogel) members undertaking radiation therapy studies primarily in mouse
and rat models and cell lines. First established in 1991, this SR has been approved and funded continuously by
the NCI CCSG since its inception. At the last CCSG renewal, the EI-SR received a merit rating of “Outstanding.”
The experience and expertise of the EI-SR Director and Managing Director offer Rogel investigators information
on dosage and treatment regimens, particularly in animal studies and with a knowledge of standard clinical
radiotherapy, to ensure experimental resources are used in an optimal way. EI-SR services are critical to Rogel
members interested in radiation biology and radiation therapy, as well as those for whom radiation serves as a
research tool.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 1: Combining PARP inhibition with radiation to sensitize HR proficient pancreatic cancers to immunotherapy
-
批准号:10554472
-
项目类别:
-
资助金额:$22.68万
-
财政年份:2023
-
负责人:Meredith A Morgan
-
依托单位:
Targeting the DNA damage response in combination with radiation to induce innate immunity and improve immunotherapy efficacy in pancreatic cancer
-
批准号:10352416
-
项目类别:
-
资助金额:$44.32万
-
财政年份:2020
-
负责人:Meredith A Morgan
-
依托单位:
Targeting the DNA damage response in combination with radiation to induce innate immunity and improve immunotherapy efficacy in pancreatic cancer
-
批准号:10574566
-
项目类别:
-
资助金额:$44.32万
-
财政年份:2020
-
负责人:Meredith A Morgan
-
依托单位:
Selective Sensitization of Pancreatic Cancer to Therapy by Chk1 and PARP1 Inhibit
-
批准号:8527743
-
项目类别:
-
资助金额:$28.56万
-
财政年份:2012
-
负责人:Meredith A Morgan
-
依托单位:
Selective Sensitization of Pancreatic Cancer to Therapy by Chk1 and PARP1 Inhibit
-
批准号:8372495
-
项目类别:
-
资助金额:$30.32万
-
财政年份:2012
-
负责人:Meredith A Morgan
-
依托单位:
Selective Sensitization of Pancreatic Cancer to Therapy by Chk1 and PARP1 Inhibit
-
批准号:9096053
-
项目类别:
-
资助金额:$35.02万
-
财政年份:2012
-
负责人:Meredith A Morgan
-
依托单位:
The role of FBXW2 as a novel lung tumor suppressor that cross-talks with oncogenic beta-TrCP and SKP2
-
批准号:10017668
-
项目类别:
-
资助金额:$36.81万
-
财政年份:2011
-
负责人:Meredith A Morgan
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: